Showing results (281-290 of 437) with videos related to
Sort By:
Pageof 44
The Journal of Clinical Investigation|January 1, 1989
Role of invading leukocytes in enhanced atrial eicosanoid production following rabbit left ventricular myocardial infarctionM S Freed, P Needleman, C G Dunkel, et al.The American Journal of Physiology|February 1, 1986
Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogsK L Goetz, B C Wang, P G Geer, et al.The American Journal of Pathology|June 1, 1997
Improved prognosis assessment for patients with bladder carcinomaT Otto, A Bex, U Schmidt, et al.Biochimica Et Biophysica Acta|September 22, 1978
A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayersR Goldman, T Facchinetti, D Bach, et al.Biochemical Pharmacology|March 10, 2001
Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivoY Eli, F Przedecki, G Levin, et al.International Journal of Oncology|May 10, 2011
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-lineP Nangiamakker, E Thompson, C Hogan, et al.Cancer Research|July 1, 1996
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptideH Watanabe, K Takehana, M Date, et al.Nature|December 13, 1984
Participation of p53 cellular tumour antigen in transformation of normal embryonic cellsD Eliyahu, A Raz, P Gruss, et al.Nature Communications|November 1, 2017
Acoel regeneration mechanisms indicate an ancient role for muscle in regenerative patterningAmelie A Raz, Mansi Srivastava, Ranja Salvamoser, et al.Cancer Research|July 4, 1998
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cellsY Niinaka, S Paku, A Haga, et al.Pageof 44